Neurotype Inc.: Funding, Investors & Team (Oct 2026)
Medical device focused on treating brain circuits that underlie drug craving caused by environmental triggers for drug use addiction healthcare. People in recovery are constantly reminded of drug use by environmental cues (people, places, things linked to prior drug use), remaining a persistent risk for relapse, overdoses, and diminished life quality. The NeuromarkR platform (headset+software) measures brain signatures of drug craving not currently addressed in gold standard addiction healthcare. NeuromarkR enables targeted interventions to address triggers for craving by tailored psychotherapy that uses Cognitive Behavioral Therapy (CBT) and Mindfulness-Based Treatment (MBT) strategies.
Neurotype Inc. has raised $330k across 1 funding round on record, the most recent a Seed of $330k announced in Jul 2023.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Neurotype Inc. Company Profile and Key Stats
Latest funding round on record: Jul 2023.
Neurotype Inc. Funding Rounds
Neurotype Inc. Founders and Leadership Team
Contact details for the Neurotype Inc. team: 1 of 1 has an email address on file.
Start 14-day free trial →Neurotype Inc. Funding Compared to Other Biotechnology Startups
Neurotype Inc.'s latest round of $330k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Neurotype Inc. in Biotechnology and Minneapolis
Companies Similar to Neurotype Inc.
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Neurotype Inc. Funding FAQs
What does Neurotype Inc. do?
Medical device focused on treating brain circuits that underlie drug craving caused by environmental triggers for drug use addiction healthcare. People in recovery are constantly reminded of drug use by environmental cues (people, places, things linked to prior drug use), remaining a persistent risk for relapse, overdoses, and diminished life quality. The NeuromarkR platform (headset+software) measures brain signatures of drug craving not currently addressed in gold standard addiction healthcare. NeuromarkR enables targeted interventions to address triggers for craving by tailored psychotherapy that uses Cognitive Behavioral Therapy (CBT) and Mindfulness-Based Treatment (MBT) strategies.
How much funding has Neurotype Inc. raised?
Neurotype Inc. has raised $330k across 1 round on record. The most recent is a Seed of $330k announced in Jul 2023.
When did Neurotype Inc. last raise funding?
Neurotype Inc.'s most recent funding round on record is a Seed of $330k, announced in Jul 2023.
Who is the CEO of Neurotype Inc.?
Scott Burwell is listed as CEO at Neurotype Inc..
Where is Neurotype Inc. headquartered?
Neurotype Inc. is based in Minneapolis, Minnesota, United States.
How many employees does Neurotype Inc. have?
Neurotype Inc. is in the 1-10 employee band.
How does Neurotype Inc.'s funding compare to other Biotechnology startups?
Neurotype Inc.'s latest round of $330k is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Neurotype Inc. Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Neurotype Inc. is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.